HLS Therapeutics Inc - ESG Rating & Company Profile powered by AI
This Sustainability rating for HLS Therapeutics Inc indicates its reporting of the United Nations SDGs. Alternative corporations in the scoring industry group for HLS Therapeutics Inc are shown below. The report of HLS Therapeutics Inc is assembled by All Street Sevva using leading Cognitive Robots.
HLS Therapeutics Inc in the Drug Retailers industry gained a UN SDG ESG Transparency Score of 3.9; made up of an environmental score of 2.7, social score of 5.7 and governance score of 3.2.
3.9
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Sapporo Clinical Laboratory Inc | 8.0 | High |
2 | Nihon Chouzai Co Ltd | 7.5 | High |
29 | Medical Ikkou Group Co Ltd | 4.0 | High |
29 | iApotek Int AB | 4.0 | High |
... | ... | ... | |
33 | HLS Therapeutics Inc | 3.9 | Medium |
33 | Yakuodo Holdings Co Ltd | 3.9 | Medium |
35 | Assured Pharmacy LLC | 3.6 | Medium |
... | ... | ... | |
70 | Zhejiang Zhenyuan Share Co Ltd | 0.0 | Low |
70 | d1000 Varejo Farma Participacoes SA | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does HLS Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Does HLS Therapeutics Inc disclose current and historical energy intensity?
Does HLS Therapeutics Inc report the average age of the workforce?
Does HLS Therapeutics Inc reference operational or capital allocation in relation to climate change?
Does HLS Therapeutics Inc disclose its ethnicity pay gap?
Does HLS Therapeutics Inc disclose cybersecurity risks?
Does HLS Therapeutics Inc offer flexible work?
Does HLS Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does HLS Therapeutics Inc disclose the number of employees in R&D functions?
Does HLS Therapeutics Inc conduct supply chain audits?
Does HLS Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does HLS Therapeutics Inc conduct 360 degree staff reviews?
Does HLS Therapeutics Inc disclose the individual responsible for D&I?
Does HLS Therapeutics Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does HLS Therapeutics Inc disclose current and / or historical scope 2 emissions?
Does HLS Therapeutics Inc disclose water use targets?
Does HLS Therapeutics Inc have careers partnerships with academic institutions?
Did HLS Therapeutics Inc have a product recall in the last two years?
Does HLS Therapeutics Inc disclose incidents of discrimination?
Does HLS Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Has HLS Therapeutics Inc issued a profit warning in the past 24 months?
Does HLS Therapeutics Inc disclose parental leave metrics?
Does HLS Therapeutics Inc disclose climate scenario or pathway analysis?
Does HLS Therapeutics Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does HLS Therapeutics Inc disclose the pay ratio of women to men?
Does HLS Therapeutics Inc support suppliers with sustainability related research and development?
Does HLS Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does HLS Therapeutics Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is HLS Therapeutics Inc involved in embryonic stem cell research?
Does HLS Therapeutics Inc disclose GHG and Air Emissions intensity?
Does HLS Therapeutics Inc disclose its waste policy?
Does HLS Therapeutics Inc report according to TCFD requirements?
Does HLS Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does HLS Therapeutics Inc disclose energy use targets?
Does HLS Therapeutics Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does HLS Therapeutics Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for HLS Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular (CV) markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsules; and PERSERIS, an injectable risperidone product for the treatment of schizophrenia. It also offers MyCare psychiatry lab assays and MyCare Insite point of care therapeutic drug-level monitoring tests. In addition, the company holds the U.S. marketing rights of Absorica, a commercial stage dermatology product; Canadian rights of Trinomia for CV therapeutics; and a portfolio of royalty interests of four healthcare products. HLS Therapeutics Inc. was founded in 2018 and is headquartered in Etobicoke, Canada.